1. 王辰 中国 中国医学科学院 2020美国医学院院士;中国工程院院士 NSFC spurs significant basic research progress of respiratory medicine in China
2. 董尔丹 中国 北京大学第三医院 中国工程院院士 NSFC spurs significant basic research progress of respiratory medicine in China
3. 张礼和 中国 北京大学 中国科学院院士 Inter-molecular beta-sheet structure facilitates lung-targeting siRNA delivery
4. 钟南山 中国 广州医科大学 中国工程院院士 Preparation of Lung-Targeting, Emodin-Loaded Polylactic Acid Microspheres and Their Properties
5. 王辰 中国 中国医学科学院 2020美国医学院院士;中国工程院院士 Pneumonia relevant to lung transplantation and pathogen distribution
6. 廖万清 中国 海军军医大学 中国工程院院士 Epidemiology of opportunistic invasive fungal infections in China: review of literature
7. Paolo,Spagnolo 意大利 University of PADUA Clinical Applications of Endobronchial Ultrasound (EBUS) Scope: Challenges and Opportunities
8. David E,Ost 美国 University of Texas MD Anderson Cancer Center An update on bronchopleural fistulae following cancer-related surgery
9. Annema, Jouke T. 荷兰 University of AMSTERDAM Diagnostic yield and safety of navigation bronchoscopy: A systematic review and meta-analysis
10. Choy, Jin Ho 日本 Tokyo Institute of Technology The emergence of nanoporous materials in lung cancer therapy
11. Vinu, Ajayan 澳大利亚 University of Newcastle The emergence of nanoporous materials in lung cancer therapy
12. Anne S,Tsao 美国 University of Texas MD Anderson Cancer Center Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II..
13. John V,Heymach 美国 University of Texas MD Anderson Cancer Center Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II..
14. Frank V,Fossella 美国 University of Texas MD Anderson Cancer Center Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II..
15. Yusuke,Yamauchi 澳大利亚 University of Queensland A novel technique to remove a foreign body in a distal bronchus in a child
16. Hans,Wildiers 比利时 Katholieke Universiteit Leuven(KU Leuven) Biomarker Analysis of the Phase III NALA Study of Neratinib plus Capecitabine versus Lapatinib plus ..
17. Sara A,Hurvitz 美国 University of California Los Angeles Biomarker Analysis of the Phase III NALA Study of Neratinib plus Capecitabine versus Lapatinib plus ..
18. Beverly,Moy 美国 Harvard University Biomarker Analysis of the Phase III NALA Study of Neratinib plus Capecitabine versus Lapatinib plus ..
19. Sung-Bae,Kim 韩国 University of Ulsan Biomarker Analysis of the Phase III NALA Study of Neratinib plus Capecitabine versus Lapatinib plus ..
20. William J,Gradishar 美国 Northwestern University Biomarker Analysis of the Phase III NALA Study of Neratinib plus Capecitabine versus Lapatinib plus ..